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ARTICLE
A Cas9 with PAM recognition for adenine
dinucleotides
Pranam Chatterjee1,2✉, Jooyoung Lee 3, Lisa Nip1,2, Sabrina R. T. Koseki 1,2, Emma Tysinger1,2,
Erik J. Sontheimer 3, Joseph M. Jacobson1,2 & Noah Jakimo1,2
CRISPR-associated (Cas) DNA-endonucleases are remarkably effective tools for genome
engineering, but have limited target ranges due to their protospacer adjacent motif (PAM)
requirements. We demonstrate a critical expansion of the targetable sequence space for a
type II-A CRISPR-associated enzyme through identification of the natural 50-NAAN-30 PAM
preference of Streptococcus macacae Cas9 (SmacCas9). To achieve efficient editing activity,
we graft the PAM-interacting domain of SmacCas9 to its well-established ortholog from
Streptococcus pyogenes (SpyCas9), and further engineer an increased efficiency variant
(iSpyMac) for robust genome editing activity. We establish that our hybrids can target all
adenine dinucleotide PAM sequences and possess robust and accurate editing capabilities in
human cells.
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B iotechnologies based on RNA-guided CRISPR systems haveenabled precise and programmable genomic interfacing1.However, CRISPR-associated (Cas) endonucleases are also
collectively restrained from localizing to any position along
double-stranded DNA (dsDNA) due to their requirement for
targets to neighbor a protospacer adajacent motif (PAM)2–4.
Current gaps in the PAM sequences that Cas enzymes are known
to recognize prevent access to numerous genomic positions for
powerful genome editing activities, such as base editing, prime
editing, and homology-directed repair5–8. Many adenine-thymine
(AT)-rich regions, in particular, have been excluded from com-
pelling CRISPR applications because previously reported endo-
nucleases, such as Cas9 and Cas12a (formerly known as Cpf1),
require targets to neighbor guanine-cytosine (GC)-content or
more restrictive motifs, respectively9–11.
In this work, we introduce an ortholog of the well-established
Cas9 from Streptococcus pyogenes (SpyCas9), derived from
Streptococcus macacae NCTC 11558, that can instead recognize a
short 50-NAA-30 PAM12. These sequences constitute 18.6%
of the human genome, making adjacent adenines the most
abundant dinucleotide (Supplementary Fig. 1A–B). The impor-
tance of this alternative PAM recognition for a Cas9 enzyme is
reinforced by recent work exposing that Type-V DNA-targeting
CRISPR nucleases (including Cas12 and Cas14 orthologs), while
targeting dsDNA at AT-rich PAM sites with intrinsic high fide-
lity, will indiscriminately digest single-stranded DNA (ssDNA)
once bound to their targets13–16. Such collateral activity may
introduce unwanted risks around partially unpaired chromoso-
mal structures, such as transcription bubbles, R-loops, and
replication forks.
Here we present engineered nucleases derived from SmacCas9
and characterize their altered specificity and utility by means of
transcriptional repression in bacterial culture, in vitro digestion
reactions, and gene editing activity in human cells. Our results
demonstrate complete 50-NAAN-30 PAM recognition of our
engineered variants in all tested contexts.
Results
Discovery of SmacCas9. To modify the ancestral 50-NGG-30 PAM
specificity of SpyCas9, early and recent reports have employed
directed evolution (e.g., "VQR”, "EQR”, "VRER”, and "NRNH”
variants) or rational design informed by crystal structure (e.g.,
"QQR”, "NG”, and "NR” variants)17–22. These reports focused on the
PAM-contacting arginine residues R1333 and R1335 that abolish
function when exclusively mutated. While those studies identified
compensatory mutations resulting in altered PAM specificity, the
Cas9 variants that they produced maintained a guanine preference
in at least one position of the PAM sequence for reported in vivo
editing. Concurrent reports have used evolutionary information to
further relax the canonical 50-NNGRRT-30 PAM specificity of Sta-
phylococcus aureus Cas9 (SaCas9) or to discover alternative 50-
NNNNCC-30 PAM specificity to the canonical 50-NNNNGHTT-30
PAM of Neisseria meningitidis Cas923,24. The nucleases from both of
these new reports, however, still prefer GC-content in at least one
position of the PAM sequence. We aimed to lift such GC-content
prerequisites via a custom bioinformatics-driven workflow that
mines existing PAM diversity in the Streptococcus genus25. Using
this strategy, we homed in on SmacCas9 as having the potential to
bear altered non-GC PAM specificity upon aligning 115 orthologs of
SpyCas9 from UniProt (limited to those with greater than a 70%
pairwise BLOSSOM62 score). From the alignment we found
SmacCas9 was one of two close homologs, along with a Strepto-
coccus mutans B112SM-A Cas9 (SmutCas9), possessing glutamines
at both of the positions aligned to the otherwise highly conserved
PAM-contacting arginines (Fig. 1a–b; Supplementary Fig. 2A).
Arginine residues are known to strongly prefer guanines in the
amino-acid-base interaction landscape, as evidenced by the 50-NGG-
30 specificity of SpyCas9. Glutamine residues, on the other hand,
preferentially bind to adenines, through interaction with the major
groove edge26. We thus hypothesized that SmacCas9 had naturally
coevolved the necessary compensatory mutations to gain new
adenine-rich PAM recognition. A small sample size of 13 spacers
from its corresponding genome’s CRISPR array prevented us from
confidently inferring the SmacCas9 PAM in silico. Nevertheless, the
possibility for SmacCas9 requiring less GC-content in its PAM was
supported by sequence similarities to the "QQR” variant that has 50-
NAAG-30 specificity27, in addition to the AT-rich putative con-
sensus PAM for phage-originating spacers in CRISPR arrays asso-
ciated with highly homologous SmutCas9, which were identified
with the aid of our previously-described SPAMALOT pipeline and
consistent with previous predictions (Fig. 1c; Supplementary Fig. 2B;
Supplementary Fig. 3) 25,28.
Engineering and PAM characterization of SpyMac. We pro-
ceeded to empirically determine the PAM preferences of several
Streptococcus orthologs that change one or both of the critical PAM-
contacts. Based on demonstrated examples of the PAM-interaction
domain (PID) and guide RNA (gRNA) having cross-compatibility
between Cas9 orthologs that are closely related and active, we
constructed new variants by rationally exchanging the PI region of
catalytically "dead” SpyCas9 (dSpyCas9) with those of the selected
orthologs (Supplementary Fig. 2A–B)29,30. Assembled variants,
including dSpyMacCas9 (herein referred to as dSpyMac), were
separately cotransformed into E. coli cells, along with guide RNA
derived from S. pyogenes and an 8-mer PAM library of uniform base
representation in the PAM-SCANR genetic circuit, established by
Leenay et al.31. The circuit upregulates a green fluorescent protein
(GFP) reporter in proportion to PAM-binding strength. Therefore,
we collected the GFP-positive cell populations by flow cytometry
(Supplementary Fig. 4) and Sanger sequenced them around the site
of the PAM to determine position-wise base preferences in a cor-
responding variant’s PAM recognition. dSpyMac, more so than
dSpyMutCas9, generated a trace profile that was most consistent
with guanine-independent PAM recognition, along with a dominant
specificity for adenine dinucleotides (Fig. 2a; Supplementary
Fig. 2C).
Next, we purified nuclease-active enzymes to continue probing
the DNA target recognition potential and uniqueness of SpyMac.
(Supplementary Fig. 5A)27,32. We individually incubated the
ribonucleoprotein complex enzymes (composed of Cas9 +
crRNA + tracrRNA) with double-stranded target substrates of
all 50/30-neighboring base combinations at an adenine dinucleo-
tide PAM (50-NAAN-30; Fig. 2b). A brief 16-min digestion
indicated both wild-type SmacCas9 and the hybrid SpyMac
cleaved adjacent to 50-NAAN-30 motifs more broadly and evenly
than the previously reported QQR variant. SpyMac distinguished
itself further with rapid DNA-cutting rates that resemble the fast
digest kinetics of SpyCas9 (Fig. 2c–d)33. We ran reactions that
used varying crRNA spacer lengths and tracrRNA sequence, as
the latter differs slightly between the S. macacae and S. pyogenes
genomes (Supplementary Fig. 5B–E). Neither of these two
parameters compensated for the slower cleavage rate of
SmacCas9, but we did notice marginal improvement in the
activity of the wild-type form with its native tracrRNA, which
comports with the interface of the guide-Cas9 interaction being
mostly outside of the PI domain.
To verify that an adenine dsDNA dinucleotide is sufficient for
Cas9 PAM recognition and target cleavage, we assembled target
sequences that switch the next four downstream bases to the same
nucleotide (e.g., 50-TAAGXXXX-30, for X all fixed to A, C, G, or
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Fig. 1 Identification of features from natural PAM divergence through bioinformatics. a Sequence alignment of SpyCas9, its QQR variant, and SmacCas9.
The step in the underlining red line marks the joining of SpyCas9 and SmacCas9 to construct a SpyMac hybrid. The sequence logo (Weblogo online tool)
immediately below the alignment depicts the conservation at 11 positions around the PAM-contacting arginines of SpyCas9. b The domain organization of
SpyCas9 juxtaposed over a color-coded structure of RNA-guided, target-bound SpyCas9 (PDB ID 5F9R). The two DNA strands are black with the
exception of a magenta segment corresponding to the PAM. A blue–green–red color map is used for labeling the Cas9 PI domain and guide spacer
sequence to highlight structures that confer sequence specificity and the prevalence of intra-domain contacts within the PI43. c A sequence logo generated
online (WebLogo) that was input with putative PAM sequences found in Streptococcus phage and associated with close SmacCas9 homologs.
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Fig. 2 Validation of SmacCas9 recognition for adenine dinucleotide PAM sequences. a Chromatograms representing the PAM-SCANR based enrichment
of variant-recognizing PAM sequences from a 50-NNNNNNNN-30 library. b SYBR-stained agarose gels showing in vitro digestion of 10 nM 50-NAAN-30
substrates upon 16 minutes of incubation with 100 nM of purified ribonucleoprotein enzyme assemblies. Arrows distinguish banding of the cleaved
products from uncleaved substrate (top band). Matrix plots summarize cleaved fraction calculations, which were carried out in a custom script for
processing gel images. Samples were performed in independent biological duplicates (n= 2). c Time course measurements of target DNA substrate
cleavage for SmacCas9 and SpyMac. d DNA substrate cleavage plotted as a function of 0.25:1, 1:1, and 4:1 molar ratios of ribonucleoprotein to target for
wild-type SpyCas9 and hybrid SpyMac. Source data are provided as a Source Data file.
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T; Supplementary Fig. 5F). We confirmed SpyMac remains active
across this target set, albeit with some variation in cutting rate.
Additionally, we observed moderate yield of cleaved products on
examples of 50-NBBAA-30, 50-NABAB-30, 50-NBABA-30 PAM
sequences (where B is C, G, or T; Supplementary Fig. 5G),
revealing an even broader tolerance for increments to the
dinucleotide position or adenine adjacency. We anticipate future
measurements of guide-loading, target-dissociation and R-loop
expansion/contraction will provide more insights on the
serendipitous catalytic benefit over SmacCas9 from grafting its
PI domain onto a truncated SpyCas9.
Genome editing with iSpyMac. To assess the altered 50-NAAN-30
targeting capabilities of SpyMac, as opposed to SpyCas9, we
cotransfected HEK293T cells with plasmids expressing these
nucleases alongside one of 12 sgRNAs, targeting PAMs with varying
combinations of bases flanking the adenine dinucleotide, within 5
distinct genomic loci. After 5 days post-transfection, we extracted
genomic DNA, amplified the target loci, and quantified indel fre-
quencies via next-generation sequencing (NGS). Our results first
demonstrate that while SpyCas9 is able to achieve over a 50%
modification rate on the 50-NGGN-30 substrate, it has negligible
activity on 50-NAAN-30 targets. Alternatively, SpyMac achieves
modification on most, but not all, tested 50-NAAN-30 loci. In fact,
SpyMac demonstrated negligible editing on the tested 50-AAAA-30
target sequence within the PVALB gene. To address sites with low
modification efficiencies, we introduced two mutations (R221K and
N394K) into SpyMac that had been previously identified by deep
mutational scans of SpyCas9 to increase editing efficiency34. We
refer to this variant as an increased editing SpyMac (iSpyMac) due
to its elevated modification efficiencies on all tested 50-NAAN-30
targets, even editing on sites that SpyMac is unable to access, such as
50-AAAA-30 PAM sites (Fig. 3a). Additionally, iSpyMac exhibits
comparable modification efficiencies to other A-rich CRISPR
nucleases, such as Cas12a effectors from Acidaminococcus sp. and
Lachnospiraceae bacterium ND2006 (Supplementary Fig. 6).
Next, we assessed the tolerance of iSpyMac to mismatched
sequences, by employing sgRNAs harboring double or single
mismatches to a fixed protospacer within the AAVS gene, possessing
a 50-GAAG-30 PAM sequence. iSpyMac demonstrated editing
capabilities on targets with single mismatches within the PAM-
proximal segment of the sgRNA. To mitigate this supposed off-
target propensity, we introduced the R691A mutation, which was
previously isolated via bacterial selection for SpyCas9 to maintain
high on-target activity while reducing off-target editing35. Our high-
fidelity variant, HiFi-iSpyMac, exhibited nearly negligible activity on
mismatched sequences, as compared to the original enzyme, with
minimal loss of on-target activity (Fig. 3b).
Lastly, we selected a window of four nucleotides in the VEGFA
locus in a sequence context such that any other CRISPR
endonuclease with reported use for base editing would not allow
their base editing with a cytidine deaminase-fused enzyme36.
Accordingly, we cotransfected HEK293T cells with a nickase form
of iSpyMac derived from the previously reported BE3 architecture
for cytosine base editing (iSpyMac-BE3) and the sgRNA plasmid
targeting a PAM downstream of the selected nucleotides5. We
measured effective base editing levels in harvested cells, which
exhibited over 20% cytosine to thymine conversion at these
positions via NGS analysis (Fig. 3c).
Discussion
In summary, we have identified a homolog of SpyCas9 in Strepto-
coccus macacae with native 50-NAAN-30 PAM specificity. By
leveraging the high similarity in Cas9 sequences between different
Streptococcus species and the substantial background in the
development and characterization of SpyCas9, we have engineered
variants of SmacCas9 that maintain its minimal adenine dinucleo-
tide PAM specificity and achieve efficient and accurate activity for
mediating edits on chromosomes in human cells37. This finding sets
the path for engineering enzymes like iSpyMac with other desirable
properties, control points, effectors, and activities8,38–40. iSpyMac
can now open wide access to AT-content PAM sequences in the
ever-growing list of genome engineering applications with type II-A
CRISPR-Cas systems.
Methods
Selection of Streptococcus Cas9 orthologs of interest. All Cas9 orthologs from
the Streptococcus genus were downloaded from the online UniProt database https://
www.uniprot.org/. These were the downselected by pairwise alignment to SpyCas9
using a BLOSUM62 cost matrix in Genewiz software, discarding orthologs with
less than 70% agreement with the Spy Cas9 sequence. The remaining 115 orthologs
were used to generate a sequence logo (Weblogo http://weblogo.threeplusone.com/
create.cgi), and were manually selected for divergence at positions aligned to
residues critical for the PAM interaction of SpyCas9. The SPAMALOT pipeline
was implemented as we previously reported25. Briefly, a set of scripts based around
the Bowtie alignment tool (http://bowtie-bio.sourceforge.net) map the spacer
sequences from CRISPR cassettes to putative targets in phage genomes. The
SPAMALOT software can be downloaded at https://github.com/mitmedialab/
SPAMALOT.
PAM-SCANR bacterial fluorescence assay. Sequences encoding the PAM-
interaction domains of selected Cas9 orthologs were synthesized as gBlock
fragments by Integrated DNA Technologies (IDT) and inserted via a New
England Biolabs (NEB) Gibson Assembly reaction into the C-terminus of a low-
copy plasmid containing dSpyCas9 (Beisel Lab, NCSU). The hybrid-protein
constructs were transformed into electrocompetent E. coli cells with additional
PAM-SCANR components as previously established31. Overnight cultures were
analyzed and sorted on a Becton Dickinson (BD) FACSAria machine. Sorted
GFP-positive cells were grown to sufficient density, and plasmids from the pre-
sorted and sorted populations were then isolated. The region flanking the
nucleotide library was PCR-amplified and submitted for Sanger sequencing
(Genewiz). The chromatograms from received trace files were inspected for post-
sorted sequence enrichments relative to the pre-sorted library.
Purification of and DNA cleavage with selected nucleases. The gBlock (IDT)
encoding the PAM-interaction domain of S. macacae was inserted into a bacterial
protein expression/purification vector containing wild-type S. pyogenes Cas9 fused to
the His6-MBP-tobacco etch virus (TEV) protease cleavage site at the N-terminus
(pMJ915 was a gift from Jennifer Doudna, Addgene plasmid #69090). The resulting
hybrid SpyMac Cas9 protein expression construct was sequence-verified by a next-
generation complete plasmid sequencing service (CCBI DNA Core Facility at Mas-
sachusetts General Hospital). The hybrid-protein construct was then transformed into
BL21 Rosetta 2TM(DE3) (MilliporeSigma), and a single colony was picked for protein
expression, inoculated in 1 L 2xYT media, and grown at 37 °C to a cell density of
OD600 0.6. The temperature was then lowered to 18 °C and His-MBP-TEV-SpyMac
Cas9 expression was induced by supplementing with 0.2 mM IPTG for an additional
18 h of growth before harvest. Cells were then lysed with BugBusterTMProtein
Extraction Reagent, supplemented with 1mg/ml lysozyme solution (MilliporeSigma),
125 Units/gram cell paste of BenzonaseTMNuclease (MilliporeSigma), and complete,
EDTA-free protease inhibitors (Roche Diagnostics Corporation). The lysate was
clarified by centrifugation, including a final spin with a prechilled SteriflipTM0.45
micron filter (MilliporeSigma). The clarified lysate was incubated with Ni-NTA resin
(Qiagen) at 4 °C for 1 h and subsequently applied to an Econo-PacTMchromatography
column (Bio-Rad Laboratories). The protein-bound resin was washed extensively with
wash buffer (20mM Tris pH 8.0, 800mM KCl, 20mM imidazole, 10% glycerol, 1 mM
TCEP) and His-tagged SpyMac protein was eluted in wash buffer (20mM HEPES, pH
8.0, 500mM KCl, 250mM imidazole, 10% glycerol). ProTEVTMPlus protease (Pro-
mega, Madison) was added to the pooled fractions and dialyzed overnight into storage
buffer (20mM HEPES, pH 7.5, 500mM KCl, 20% glycerol) at 4 °C using Slide-A-
LyzerTMdialysis cassettes with a molecular weight cutoff of 20 KDa (ThermoFisher
Scientific). The sample was then incubated again with Ni-NTA resin for 1 h at 4 °C
with gentle rotation and applied to a chromatography column to remove the cleaved
His tag. The protein was eluted with wash buffer (20mM Tris pH 8.0, 800mM KCl,
20mM imidazole, 10% glycerol, 1 mM TCEP) and fractions containing cleaved pro-
tein were verified once more by SDS-PAGE and Coomassie staining, then pooled,
buffer exchanged into storage buffer, and concentrated. The concentrated aliquots
were measured based on their light-absorption (Implen Nanophotometer) and flash-
frozen at −80 °C for storage or used directly for in vitro cleavage assays. The crRNA
and tracrRNA guide components were procured in the form of HPLC-purified RNA
oligos (IDT) and resuspended in 1X IDTE pH 7.5 solution (IDT). Duplex crRNA-
tracrRNA guides were annealed at 1 uM concentration in duplex buffer (IDT) by a
protocol of rapid melting followed by gradual cooling. Target substrates were PCR-
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amplified from assemblies of the PAM-SCANR plasmid with a fixed PAM sequence.
In vitro digestion reactions with 10 nM target and typically a 10-fold excess of enzyme
components were prepared on ice and then incubated in a thermal cycler at 37 °C.
Reactions were halted after at least 1min of incubation by subsequent heat dena-
turation at 65 °C for 5min and run on a 2% TAE-agarose gel stained with DNA-
intercalating SYBR dye (Invitrogen). Gel images were recorded from blue-light
exposure and analyzed in a Python script adapted from https://github.com/jharman25/
gelquant/. Cleavage fraction measurements were quantified, in ImageJ (imagej.nih.gov)
by the relative intensity of substrate and product bands as follows:
% cleaved fraction ¼ Integrated intensity of product bands
Integrated intensity of all bands
Cell culture and DNA modification analysis. HEK293T cells were maintained in
DMEM supplemented with 100 units/ml penicillin, 100 mg/ml streptomycin,
and 10% fetal bovine serum (FBS). sgRNA plasmids (100 ng) and nuclease
plasmids (100 ng) were transfected into cells as duplicates (2 × 104/well in a 96-
well plate) with Lipofectamine 3000 (Invitrogen) in Opti-MEM (Gibco). After
5 days post-transfection, genomic DNA was extracted using QuickExtract
Solution (Epicentre), and genomic loci were amplified by PCR utilizing the
Phusion Hot Start Flex DNA Polymerase (NEB). Amplicons were enzymatically
purified and submitted for Sanger sequencing or NGS sequencing. Sanger
sequencing ab1 files were analyzed using the TIDE algorithm (tide.deskgen.com)
41. in comparison to an unedited control to calculate indel frequencies. NGS
FASTQ files were analysed using a batch version of the software CRISPResso2
(https://github.com/pinellolab/CRISPResso2)42. All samples were performed in
independent duplicates (n= 2). Standard deviation was used to calculate
error bars.
Statistical analysis. Data are shown as the mean of duplicate values, which are
indicated by dots for each figure. Data were plotted using Matplotlib and the
GraphPad Prism software (graphpad.com/scientific-software/prism/).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data that support the findings of this study are available via the NIH Sequence
Read Archive via BioProject PRJNA623926. Data underlying Figs. 2-3 and
Supplementary Fig. 6 are provided as Source Data.
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